The American Cancer Society estimates that about 7,500 American men will develop testicular cancer in 2002. Although testicular cancer is a rare cancer and accounts for one percent of all cancers in men, it is the most common form of cancer in men ages 15 to 35 years.

Specialists from the Urologic Cancer Care Team meet weekly to review each new patient’s case and devise an individualized treatment plan. Men with testicular cancer usually have an excellent prognosis. Testicular cancer is considered curable with state of the art treatment, including surgery, chemotherapy, and radiation therapy.

For more information about Risk factors, symptoms, screening guidelines, and treatment options, please click on the NCI (Fact Sheet 6.43)